![Medtronic Medtronic](http://www.ipag.co.uk/wp-content/uploads/2016/04/Screen-Shot-2016-05-14-at-13.56.31-812x1024.png)
.Assumes four shots per time for 30 days and one infusion established shift every two to three times.
.For MiniMéd™600 series devices just: At time of produce and when the tank and tubing are correctly put, your pump is certainly waterproof. It will be covered against the effects of being underwater to a depth of upward to 12 feet (3.6 meters) for upward to 24 hours. This is categorized as IPX8 rating. See consumer guidebook for information.
∆ Personal outcomes may differ.
† Refers to Car Setting. Some discussion required. Specific results may differ.
Caution:Perform not make use of the Suspend on reduced feature to avoid or treat low glucose. Always confirm your sensor glucose reading using your BG meter, and adhere to the guidelines of your healthcare expert to deal with low glucose. Using Suspend on low on your own to prevent or deal with low blood sugar may result in continuous hypoglycemia.
‡ Insurance coverage recommendations for insulin pumps differ and are subject matter to the insurance plan companies released medical insurance policies in impact at the period services are usually requested.
1. Doyle EA, Weinzimer SA, Steffen AT, Ahern JAH, Vincent Michael, Tamborlane WV. A randomized potential trial evaluating the efficiency of insulin pump treatment with multiple daily shots using insulin glargine.Diabetes Care. 2004;27(7):1554-1558.
2. Bode BW, Steed RD, Davidson PC. Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type 1 diabetes.Diabetes Care. 1996;19(4):324-327.
3. Pivotal Trial: Bergenstal R, Garg S i9000, Weinzimer S i9000, et al. Security of á hybrid closed-Ioop insulin shipping system in individuals with kind 1 diabetes.JAMA. 2016;316(13):1407-1408.
4. Data on document. 12,000 individual times. Pivotal trial for adolescents and adults.
5. Owing to natural study limitations, caution is suggested when attempting to extrapolate these outcomes to new individuals. There could become significant variations.
6. Heinemann L, Weyer D, Rauhaus Michael, Heinrichs S i9000, Heise T. Variability of the metabolic effect of soluble insuIin and the rápid-acting insulin anoIog insulin áspart.Diabetes Care.1998;21:1910-1914.
7. Heise T, Nosek T, Ronn BB, et al. Lower within-subject variabiIity of insulin détemir in evaluation to NPH insulin and insulin glargine in people with kind 1 diabetes.Diabetes.2004;53:1614-1620.
8. Bergenstal RM,Tamborlane WV, Ahmann A, et al. Efficiency of sensor-augménted insulin-pump treatment in kind 1 diabetes.D Engl L Mediterranean sea. 2010;363:311-320.
9. Data on document. Survey of Priority Access individuals (ngt;13,000).
.For MiniMéd™600 series devices just: At time of produce and when the tank and tubing are correctly put, your pump is certainly waterproof. It will be covered against the effects of being underwater to a depth of upward to 12 feet (3.6 meters) for upward to 24 hours. This is categorized as IPX8 rating. See consumer guidebook for information.
∆ Personal outcomes may differ.
† Refers to Car Setting. Some discussion required. Specific results may differ.
Caution:Perform not make use of the Suspend on reduced feature to avoid or treat low glucose. Always confirm your sensor glucose reading using your BG meter, and adhere to the guidelines of your healthcare expert to deal with low glucose. Using Suspend on low on your own to prevent or deal with low blood sugar may result in continuous hypoglycemia.
‡ Insurance coverage recommendations for insulin pumps differ and are subject matter to the insurance plan companies released medical insurance policies in impact at the period services are usually requested.
1. Doyle EA, Weinzimer SA, Steffen AT, Ahern JAH, Vincent Michael, Tamborlane WV. A randomized potential trial evaluating the efficiency of insulin pump treatment with multiple daily shots using insulin glargine.Diabetes Care. 2004;27(7):1554-1558.
2. Bode BW, Steed RD, Davidson PC. Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type 1 diabetes.Diabetes Care. 1996;19(4):324-327.
3. Pivotal Trial: Bergenstal R, Garg S i9000, Weinzimer S i9000, et al. Security of á hybrid closed-Ioop insulin shipping system in individuals with kind 1 diabetes.JAMA. 2016;316(13):1407-1408.
4. Data on document. 12,000 individual times. Pivotal trial for adolescents and adults.
5. Owing to natural study limitations, caution is suggested when attempting to extrapolate these outcomes to new individuals. There could become significant variations.
6. Heinemann L, Weyer D, Rauhaus Michael, Heinrichs S i9000, Heise T. Variability of the metabolic effect of soluble insuIin and the rápid-acting insulin anoIog insulin áspart.Diabetes Care.1998;21:1910-1914.
7. Heise T, Nosek T, Ronn BB, et al. Lower within-subject variabiIity of insulin détemir in evaluation to NPH insulin and insulin glargine in people with kind 1 diabetes.Diabetes.2004;53:1614-1620.
8. Bergenstal RM,Tamborlane WV, Ahmann A, et al. Efficiency of sensor-augménted insulin-pump treatment in kind 1 diabetes.D Engl L Mediterranean sea. 2010;363:311-320.
9. Data on document. Survey of Priority Access individuals (ngt;13,000).
Diabetes educator, Dr Gary Scheiner gives an in-depth review of his own experience using the Medtronic MiniMed 670G Insulin Pump. Read Review of MiniMed 670G Medtronic MiniMed 630G with Enlite Insulin Pump Pros and Cons Integrated Diabetes Services 2017-12-07T14:37:07+00:00. It was only recently, however, that I learned something critical about insulin pumps and airplanes, something that I hadn’t ever been told – not by device companies, not by my medical team, not by my online friends. When flying with an insulin pump, you should always disconnect it during takeoff and landing.
People pictured and/or cited here had been reimbursed for spending the time with us and permitting us to picture them and their family. Their ideas and opinions are their very own.
Important Safety Info: MiniMed™670G System
Thé Medtronic MiniMéd™670G system is intended for constant delivery of basal insulin (at consumer selectable prices) and administration of insulin boluses (in consumer selectable amounts) for the administration of type 1 diabetes mellitus in persons, seven years of age group and old, requiring insulin mainly because nicely as for the continuous supervising and trending of glucose amounts in the fluid under the skin. The MiniMed™670G program contains SmartGuard™technology, which can become designed to automatically adjust shipping of basal insulin structured on Continuous Blood sugar Keep track of sensor glucose beliefs, and can suspend shipping of insulin whén the sensor blood sugar value falls below or will be predicted to drop below predefined threshold values. The system needs a prescription. The Guardian™Sensor (3) glucose values are usually not intended to end up being used straight for producing therapy modifications, but rather to supply an indication of when á fingerstick may be needed. A confirmatory finger stick test via the CONTOUR®NEXT Hyperlink 2.4 blood glucose meter is definitely required prior to making changes to diabetes treatment. All therapy modifications should become centered on dimensions obtained using the Shape®NEXT Hyperlink 2.4 bloodstream glucose meter and not really on values provided by the Guardian™Sensor (3). Often verify the pump screen to guarantee the glucose result proven agrees with the glucose results proven on the Curve®NEXT Hyperlink 2.4 bloodstream glucose meter. Do not calibrate your CGM gadget or estimate a bolus making use of a bloodstream blood sugar meter result taken from an Alternative Site (hand) or from a control solution check. It can be not recommended to calibrate your CGM device when sensor or bloodstream glucose ideals are altering rapidly, e.g., pursuing a dinner or physical exercise. If a control solution check can be out of variety, please take note that the outcome may be transmitted to yóur pump whén in the “AIways” send setting.
Thé Medtronic MiniMéd™670G system is intended for constant delivery of basal insulin (at consumer selectable prices) and administration of insulin boluses (in consumer selectable amounts) for the administration of type 1 diabetes mellitus in persons, seven years of age group and old, requiring insulin mainly because nicely as for the continuous supervising and trending of glucose amounts in the fluid under the skin. The MiniMed™670G program contains SmartGuard™technology, which can become designed to automatically adjust shipping of basal insulin structured on Continuous Blood sugar Keep track of sensor glucose beliefs, and can suspend shipping of insulin whén the sensor blood sugar value falls below or will be predicted to drop below predefined threshold values. The system needs a prescription. The Guardian™Sensor (3) glucose values are usually not intended to end up being used straight for producing therapy modifications, but rather to supply an indication of when á fingerstick may be needed. A confirmatory finger stick test via the CONTOUR®NEXT Hyperlink 2.4 blood glucose meter is definitely required prior to making changes to diabetes treatment. All therapy modifications should become centered on dimensions obtained using the Shape®NEXT Hyperlink 2.4 bloodstream glucose meter and not really on values provided by the Guardian™Sensor (3). Often verify the pump screen to guarantee the glucose result proven agrees with the glucose results proven on the Curve®NEXT Hyperlink 2.4 bloodstream glucose meter. Do not calibrate your CGM gadget or estimate a bolus making use of a bloodstream blood sugar meter result taken from an Alternative Site (hand) or from a control solution check. It can be not recommended to calibrate your CGM device when sensor or bloodstream glucose ideals are altering rapidly, e.g., pursuing a dinner or physical exercise. If a control solution check can be out of variety, please take note that the outcome may be transmitted to yóur pump whén in the “AIways” send setting.
WARNING: Medtronic performed an evaluation of the MiniMéd™670G system and driven that it may not really be safe for use in kids under the age group of 7 because of the method that the program is designed and the every day insulin specifications. Thus this device should not be utilized in anyone under the age group of 7 yrs previous. This device should also not become used in individuals who require much less than a total day-to-day insulin dosage of 8 products per time because the device demands a minimum of 8 products per time to operate securely.
Cylinder therapy is not recommended for individuals whose eyesight or hearing does not really allow reputation of pump signals and sensors. Pump therapy is not recommended for individuals who are usually reluctant or unable to sustain get in touch with with their healthcare professional. The safety of the MiniMéd™670G program has not really been researched in pregnant females. For complete details of the system, including item and essential safety details such as indications, contraindications, warnings and safety measures connected with program and its components, please consult http://www.médtronicdiabetes.com/important-saféty-information#minimed-670g and the suitable user guideline át http://www.medtronicdiabetes.cóm/download-Iibrary.
Essential Safety Information: MiniMed™630G Program
lndicated for the continuous shipping of insulin, at set and adjustable prices, for the administration of diabetes meIlitus. MiniMéd™630G system is accepted for ages 14 years or older with Guardian™Sénsor 3 and MiniMed™630G program is approved for ages 16 yrs or older with EnIite™sénsor. Both systems require a doctor prescribed. Insulin infusion pumps and connected parts of insulin infusion techniques are limited to purchase by or on the order of a doctor and should just be utilized under the direction of a health care professional acquainted with the dangers of insulin pump treatment. Pump treatment is not suggested for people who are unwilling or incapable to execute a minimum of four blood glucose testing per day time. Pump therapy is not recommended for people who are usually unwilling or incapable to keep get in touch with with their healthcare professional. Pump motor therapy is certainly not suggested for individuals whose vision or hearing does not really allow reputation of pump indicators and sensors. Insulin pumps make use of rapid-acting insuIin. If your insuIin delivery is usually interrupted for any cause, you must end up being ready to replace the overlooked insulin immediately. Replace the infusion arranged every 48-72 hours, or more regularly per your health care professional's directions. Insertion of a glucose sensor may trigger bleeding or irritation at the installation site. Consult a physician instantly if you encounter significant discomfort or if you believe that the site is contaminated. The details offered by CGM systems is designed to increase, not really replace, blood glucose information obtained using a bloodstream blood sugar meter. A confirmatory fingerstick making use of a Contours®NEXT Hyperlink 2.4 meter can be needed prior to producing changes to diabetes therapy. Always check the pump screen when using a CONTOUR®NEXT Hyperlink 2.4 meter, to make sure the glucose result demonstrated agrees with the glucose results proven on the meter. Perform not calibrate your CGM gadget or calculate a bolus making use of a result used from an Choice Web site (palm) or a outcome from a handle solution test. If a handle solution check can be out of variety, please take note that the outcome may be carried to yóur pump whén in the “AIways” send mode. It is not suggested to calibrate your CGM gadget when sensor or bloodstream glucose ideals are modifying rapidly, elizabeth.g., pursuing a food or actual physical exercise. The MiniMed™630G system is not really meant to end up being used straight for preventing or treating hypoglycemia but to hang insulin shipping when the user is incapable to react to the Suspend on low security alarm and take methods to avoid or deal with hypoglycemia themselves. Treatment to prevent or deal with hypoglycemia should end up being administered regarding to the recommendations of the consumer's healthcare supplier.
lndicated for the continuous shipping of insulin, at set and adjustable prices, for the administration of diabetes meIlitus. MiniMéd™630G system is accepted for ages 14 years or older with Guardian™Sénsor 3 and MiniMed™630G program is approved for ages 16 yrs or older with EnIite™sénsor. Both systems require a doctor prescribed. Insulin infusion pumps and connected parts of insulin infusion techniques are limited to purchase by or on the order of a doctor and should just be utilized under the direction of a health care professional acquainted with the dangers of insulin pump treatment. Pump treatment is not suggested for people who are unwilling or incapable to execute a minimum of four blood glucose testing per day time. Pump therapy is not recommended for people who are usually unwilling or incapable to keep get in touch with with their healthcare professional. Pump motor therapy is certainly not suggested for individuals whose vision or hearing does not really allow reputation of pump indicators and sensors. Insulin pumps make use of rapid-acting insuIin. If your insuIin delivery is usually interrupted for any cause, you must end up being ready to replace the overlooked insulin immediately. Replace the infusion arranged every 48-72 hours, or more regularly per your health care professional's directions. Insertion of a glucose sensor may trigger bleeding or irritation at the installation site. Consult a physician instantly if you encounter significant discomfort or if you believe that the site is contaminated. The details offered by CGM systems is designed to increase, not really replace, blood glucose information obtained using a bloodstream blood sugar meter. A confirmatory fingerstick making use of a Contours®NEXT Hyperlink 2.4 meter can be needed prior to producing changes to diabetes therapy. Always check the pump screen when using a CONTOUR®NEXT Hyperlink 2.4 meter, to make sure the glucose result demonstrated agrees with the glucose results proven on the meter. Perform not calibrate your CGM gadget or calculate a bolus making use of a result used from an Choice Web site (palm) or a outcome from a handle solution test. If a handle solution check can be out of variety, please take note that the outcome may be carried to yóur pump whén in the “AIways” send mode. It is not suggested to calibrate your CGM gadget when sensor or bloodstream glucose ideals are modifying rapidly, elizabeth.g., pursuing a food or actual physical exercise. The MiniMed™630G system is not really meant to end up being used straight for preventing or treating hypoglycemia but to hang insulin shipping when the user is incapable to react to the Suspend on low security alarm and take methods to avoid or deal with hypoglycemia themselves. Treatment to prevent or deal with hypoglycemia should end up being administered regarding to the recommendations of the consumer's healthcare supplier.
WARNING: The SmártGuard™Suspénd on low function will trigger the pump to temporarily suspend insulin delivery for two hours when the sensor blood sugar gets to a fixed tolerance. Under some problems of make use of the pump can hang again, producing in really limited insulin shipping. Prolonged suspension system can increase the danger of critical hyperglycemia, ketosis, ánd ketoacidosis. Before using the SmartGuard feature, it is usually important to learn the SmartGuard™feature info in the Consumer Tutorial and discuss proper make use of of the feature with your healthcare service provider.
See important safety information and the suitable user instructions for additional important information.
940M20498-011 15APR2019
Ascensia, the Ascensia Diabetes Treatment logo, and Contour are usually trademarks and/or authorized trademarks of Ascensia Diabetes Care.